 - This is a dose-escalation study in which 3 participants will be given a particular starting dose of RAD001 on a certain schedule. If the dose and schedule are well tolerated, then the next 3 participants enrolled will be assigned a new dosing schedule andor a higher dose of RAD001. This will continue until a maximum tolerated dose MTD is reached for RAD001. 